Literature DB >> 14747538

Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.

Tomasz I Michalak1, Patricia M Mulrooney, Carla S Coffin.   

Abstract

Woodchuck hepatitis virus (WHV), which is closely related to human hepatitis B virus and is considered to be principally hepatotropic, invades the host's lymphatic system and persists in lymphoid cells independently of whether the infection is symptomatic and serologically evident or concealed. In this study, we show, with the woodchuck model of hepatitis B, that hepadnavirus can establish an infection that engages the lymphatic system, but not the liver, and persists in the absence of virus serological markers, including antiviral antibodies. This primary occult infection is caused by wild-type virus invading the host at a quantity usually not greater than 10(3) virions. It is characterized by trace virus replication progressing in lymphatic organs and peripheral lymphoid cells that, with time, may also spread to the liver. The infection is transmissible to virus-naive hosts as an asymptomatic, indefinitely long, occult carriage of small amounts of biologically competent virus. In contrast to residual silent WHV persistence, which normally endures after the resolution of viral hepatitis and involves the liver, primary occult infection restricted to the lymphatic system does not protect against reinfection with a large, liver-pathogenic WHV dose; however, the occult infection is associated with a swift recovery from hepatitis caused by the superinfection. Our study documents that the lymphatic system is the primary target of WHV infection when small quantities of virions invade a susceptible host.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747538      PMCID: PMC369489          DOI: 10.1128/jvi.78.4.1730-1738.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 2.  Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

Authors:  C Bréchot; V Thiers; D Kremsdorf; B Nalpas; S Pol; P Paterlini-Bréchot
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

3.  Occult hepatitis B virus infection: a hidden menace?

Authors:  H S Conjeevaram; A S Lok
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

4.  Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.

Authors:  H Yotsuyanagi; Y Shintani; K Moriya; H Fujie; T Tsutsumi; T Kato; K Nishioka; T Takayama; M Makuuchi; S Iino; S Kimura; K Koike
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

5.  High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology.

Authors:  I Chemin; F Zoulim; P Merle; A Arkhis; M Chevallier; A Kay; L Cova; P Chevallier; B Mandrand; C Trépo
Journal:  J Hepatol       Date:  2001-03       Impact factor: 25.083

6.  De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.

Authors:  M Prieto; M D Gómez; M Berenguer; J Córdoba; J M Rayón; M Pastor; A García-Herola; D Nicolás; D Carrasco; J F Orbis; J Mir; J Berenguer
Journal:  Liver Transpl       Date:  2001-01       Impact factor: 5.799

7.  Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection.

Authors:  T I Michalak; P D Hodgson; N D Churchill
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation.

Authors:  J Bläckberg; K Kidd-Ljunggren
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

9.  Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases.

Authors:  M Cabrerizo; J Bartolomé; C Caramelo; G Barril; V Carreno
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

10.  In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.

Authors:  Y Y Lew; T I Michalak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more
  30 in total

Review 1.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Genetic linkage of hepatitis B virus in peripheral blood leukocytes provides evidence for contamination.

Authors:  Chloe L Thio; Stuart C Ray; Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2010-02       Impact factor: 5.103

3.  Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

Authors:  C S Coffin; P M Mulrooney-Cousins; M G Peters; G van Marle; J P Roberts; T I Michalak; N A Terrault
Journal:  J Viral Hepat       Date:  2011-06       Impact factor: 3.728

4.  Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.

Authors:  Jinguo Wang; Tomasz I Michalak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Occult hepatitis B virus infection in Egypt.

Authors:  Ashraf Elbahrawy; Alshimaa Alaboudy; Walid El Moghazy; Ahmed Elwassief; Ahmed Alashker; Abdallah Mahmoud Abdallah
Journal:  World J Hepatol       Date:  2015-06-28

6.  Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus.

Authors:  Haruki Komatsu; Ayano Inui; Tsuyoshi Sogo; Eitaro Hiejima; Akihiko Tateno; Paul Klenerman; Tomoo Fujisawa
Journal:  BMC Infect Dis       Date:  2010-04-28       Impact factor: 3.090

7.  Compartmentalization of hepatitis B virus: Looking beyond the liver.

Authors:  Sibnarayan Datta
Journal:  World J Hepatol       Date:  2015-09-18

8.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

Authors:  Tram N Q Pham; Sonya A MacParland; Patricia M Mulrooney; Helen Cooksley; Nikolai V Naoumov; Tomasz I Michalak
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation.

Authors:  Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Partha K Chandra; Arup Banerjee; Pradip K Mahapatra; Chinmoy K Panda; Shekhar Chakrabarti; Sujit K Bhattacharya; Kuntal Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.